{"result": "{\n    \"title\": \"Septic Shock Treatment and Clinical Trials\",\n    \"summary\": \"This report focuses on the interconnected entities involved in the treatment and clinical trials for septic shock, particularly highlighting the roles and relationships of Drotrecogin Alfa (activated), Hydrocortisone-plus-Fludrocortisone, Xigris, the APROCCHSS trial, and the French Ministry of Social Affairs and Health. It explores the impact of these entities on the medical community's approach to septic shock treatment, emphasizing the withdrawal of Drotrecogin Alfa (activated) from the market and the outcomes of related clinical trials.\",\n    \"rating\": 7.5,\n    \"rating_explanation\": \"The impact severity rating is high due to the significant implications of the withdrawal of a once-promising treatment and the ongoing search for effective septic shock therapies.\",\n    \"findings\": [\n        {\n            \"summary\": \"Withdrawal of Drotrecogin Alfa (activated) and its impact\",\n            \"explanation\": \"Drotrecogin Alfa (activated), also known as Xigris, was a key medication in the treatment of septic shock but was withdrawn from the market in 2011 due to concerns over its efficacy and safety. This withdrawal marked a significant shift in the treatment landscape of septic shock, highlighting the challenges in developing effective therapies for this condition. The withdrawal was based on the results of subsequent trials that failed to confirm its survival benefit for patients, leading to a reassessment of its efficacy. [Data: Entities (89, 92); Relationships (14, 138)]\"\n        },\n        {\n            \"summary\": \"The role of Hydrocortisone-plus-Fludrocortisone in septic shock treatment\",\n            \"explanation\": \"Hydrocortisone-plus-Fludrocortisone represents an alternative therapeutic approach evaluated for its effectiveness in treating septic shock. The therapy showed a reduction in 90-day all-cause mortality compared to placebo, indicating its potential as a viable treatment option. This finding underscores the ongoing efforts to identify effective treatments for septic shock and the importance of clinical trials in validating these therapies. [Data: Entities (88); Relationships (13, 136)]\"\n        },\n        {\n            \"summary\": \"APROCCHSS trial's contribution to septic shock research\",\n            \"explanation\": \"The APROCCHSS trial, funded by the French Ministry of Social Affairs and Health, played a crucial role in evaluating the effectiveness of various therapies, including Hydrocortisone-plus-Fludrocortisone, in the management of septic shock. Despite the withdrawal of Drotrecogin Alfa (activated), the trial continued to provide valuable insights into the treatment of this condition, contributing to the body of knowledge on septic shock management. [Data: Entities (90, 91); Relationships (139, 143, 141, 142)]\"\n        },\n        {\n            \"summary\": \"Funding and support for septic shock research\",\n            \"explanation\": \"The French Ministry of Social Affairs and Health, through the Programme Hospitalier de Recherche Clinique 2007, demonstrated significant support for septic shock research by funding the APROCCHSS trial. This support underscores the importance of governmental and institutional backing in advancing medical research and the development of new therapies. [Data: Entities (91, 93); Relationships (141, 142)]\"\n        },\n        {\n            \"summary\": \"The interconnectedness of entities in septic shock treatment research\",\n            \"explanation\": \"The relationships between Drotrecogin Alfa (activated), Hydrocortisone-plus-Fludrocortisone, Xigris, the APROCCHSS trial, and the French Ministry of Social Affairs and Health illustrate the complex ecosystem involved in septic shock treatment research. These connections highlight the collaborative efforts required to advance medical knowledge and develop effective treatments for challenging conditions like septic shock. [Data: Relationships (139, 140, 143, 136, 141, 142)]\"\n        }\n    ]\n}", "input": "\nYou are an AI assistant that helps a human analyst to perform general information discovery. Information discovery is the process of identifying and assessing relevant information associated with certain entities (e.g., organizations and individuals) within a network.\n\n# Goal\nWrite a comprehensive report of a community, given a list of entities that belong to the community as well as their relationships and optional associated claims. The report will be used to inform decision-makers about information associated with the community and their potential impact. The content of this report includes an overview of the community's key entities, their legal compliance, technical capabilities, reputation, and noteworthy claims.\n\n# Report Structure\n\nThe report should include the following sections:\n\n- TITLE: community's name that represents its key entities - title should be short but specific. When possible, include representative named entities in the title.\n- SUMMARY: An executive summary of the community's overall structure, how its entities are related to each other, and significant information associated with its entities.\n- IMPACT SEVERITY RATING: a float score between 0-10 that represents the severity of IMPACT posed by entities within the community.  IMPACT is the scored importance of a community.\n- RATING EXPLANATION: Give a single sentence explanation of the IMPACT severity rating.\n- DETAILED FINDINGS: A list of 5-10 key insights about the community. Each insight should have a short summary followed by multiple paragraphs of explanatory text grounded according to the grounding rules below. Be comprehensive.\n\nReturn output as a well-formed JSON-formatted string with the following format:\n    {{\n        \"title\": <report_title>,\n        \"summary\": <executive_summary>,\n        \"rating\": <impact_severity_rating>,\n        \"rating_explanation\": <rating_explanation>,\n        \"findings\": [\n            {{\n                \"summary\":<insight_1_summary>,\n                \"explanation\": <insight_1_explanation>\n            }},\n            {{\n                \"summary\":<insight_2_summary>,\n                \"explanation\": <insight_2_explanation>\n            }}\n        ]\n    }}\n\n# Grounding Rules\n\nPoints supported by data should list their data references as follows:\n\n\"This is an example sentence supported by multiple data references [Data: <dataset name> (record ids); <dataset name> (record ids)].\"\n\nDo not list more than 5 record ids in a single reference. Instead, list the top 5 most relevant record ids and add \"+more\" to indicate that there are more.\n\nFor example:\n\"Person X is the owner of Company Y and subject to many allegations of wrongdoing [Data: Reports (1), Entities (5, 7); Relationships (23); Claims (7, 2, 34, 64, 46, +more)].\"\n\nwhere 1, 5, 7, 23, 2, 34, 46, and 64 represent the id (not the index) of the relevant data record.\n\nDo not include information where the supporting evidence for it is not provided.\n\n\n# Example Input\n-----------\nText:\n\nEntities\n\nid,entity,description\n5,VERDANT OASIS PLAZA,Verdant Oasis Plaza is the location of the Unity March\n6,HARMONY ASSEMBLY,Harmony Assembly is an organization that is holding a march at Verdant Oasis Plaza\n\nRelationships\n\nid,source,target,description\n37,VERDANT OASIS PLAZA,UNITY MARCH,Verdant Oasis Plaza is the location of the Unity March\n38,VERDANT OASIS PLAZA,HARMONY ASSEMBLY,Harmony Assembly is holding a march at Verdant Oasis Plaza\n39,VERDANT OASIS PLAZA,UNITY MARCH,The Unity March is taking place at Verdant Oasis Plaza\n40,VERDANT OASIS PLAZA,TRIBUNE SPOTLIGHT,Tribune Spotlight is reporting on the Unity march taking place at Verdant Oasis Plaza\n41,VERDANT OASIS PLAZA,BAILEY ASADI,Bailey Asadi is speaking at Verdant Oasis Plaza about the march\n43,HARMONY ASSEMBLY,UNITY MARCH,Harmony Assembly is organizing the Unity March\n\nOutput:\n{{\n    \"title\": \"Verdant Oasis Plaza and Unity March\",\n    \"summary\": \"The community revolves around the Verdant Oasis Plaza, which is the location of the Unity March. The plaza has relationships with the Harmony Assembly, Unity March, and Tribune Spotlight, all of which are associated with the march event.\",\n    \"rating\": 5.0,\n    \"rating_explanation\": \"The impact severity rating is moderate due to the potential for unrest or conflict during the Unity March.\",\n    \"findings\": [\n        {{\n            \"summary\": \"Verdant Oasis Plaza as the central location\",\n            \"explanation\": \"Verdant Oasis Plaza is the central entity in this community, serving as the location for the Unity March. This plaza is the common link between all other entities, suggesting its significance in the community. The plaza's association with the march could potentially lead to issues such as public disorder or conflict, depending on the nature of the march and the reactions it provokes. [Data: Entities (5), Relationships (37, 38, 39, 40, 41,+more)]\"\n        }},\n        {{\n            \"summary\": \"Harmony Assembly's role in the community\",\n            \"explanation\": \"Harmony Assembly is another key entity in this community, being the organizer of the march at Verdant Oasis Plaza. The nature of Harmony Assembly and its march could be a potential source of threat, depending on their objectives and the reactions they provoke. The relationship between Harmony Assembly and the plaza is crucial in understanding the dynamics of this community. [Data: Entities(6), Relationships (38, 43)]\"\n        }},\n        {{\n            \"summary\": \"Unity March as a significant event\",\n            \"explanation\": \"The Unity March is a significant event taking place at Verdant Oasis Plaza. This event is a key factor in the community's dynamics and could be a potential source of threat, depending on the nature of the march and the reactions it provokes. The relationship between the march and the plaza is crucial in understanding the dynamics of this community. [Data: Relationships (39)]\"\n        }},\n        {{\n            \"summary\": \"Role of Tribune Spotlight\",\n            \"explanation\": \"Tribune Spotlight is reporting on the Unity March taking place in Verdant Oasis Plaza. This suggests that the event has attracted media attention, which could amplify its impact on the community. The role of Tribune Spotlight could be significant in shaping public perception of the event and the entities involved. [Data: Relationships (40)]\"\n        }}\n    ]\n}}\n\n\n# Real Data\n\nUse the following text for your answer. Do not make anything up in your answer.\n\nText:\n-----Entities-----\nhuman_readable_id,title,description,degree\n89,DROTRECOGIN ALFA (ACTIVATED),\"Drotrecogin alfa (activated) was a medication specifically used in the treatment of septic shock. Initially, it was considered a promising therapy and was tested in various trials, including the APROCCHSS trial, which explored its interaction with corticosteroids in the management of septic shock. Despite its early use, drotrecogin alfa (activated) was withdrawn from the market in 2011. This decision was made after subsequent trials failed to confirm its survival benefit for patients, leading to a reassessment of its efficacy and relevance in septic shock treatment. Consequently, its significance in the medical community diminished following its market withdrawal, marking the end of its use as a treatment method for septic shock.\",5\n88,HYDROCORTISONE-PLUS-FLUDROCORTISONE,\"A therapy evaluated in a clinical trial for its effectiveness in treating septic shock, showing a reduction in 90-day all-cause mortality compared to placebo\",2\n92,XIGRIS,\"Xigris, the brand name for drotrecogin alfa (activated), was a drug used in the treatment of septic shock. It was the commercial form of drotrecogin alfa (activated) available on the market. However, Xigris was withdrawn from the market in October 2011. This withdrawal was due to concerns over its efficacy and safety, leading to its discontinuation. The decision to withdraw Xigris was consistent across all descriptions, highlighting its removal from the market in 2011 after being identified as a treatment option for septic shock.\",2\n90,APROCCHSS,The clinical trial named Activated Protein C and Corticosteroids for Human Septic Shock that evaluated the effect of hydrocortisone-plus-fludrocortisone therapy on septic shock patients,4\n91,FRENCH MINISTRY OF SOCIAL AFFAIRS AND HEALTH,The funding body for the APROCCHSS clinical trial through Programme Hospitalier de Recherche Clinique 2007,1\n93,PROGRAMME HOSPITALIER DE RECHERCHE CLINIQUE 2007,No Description,1\n\n\n-----Relationships-----\nhuman_readable_id,source,target,description,rank\n14,SEPTIC SHOCK,DROTRECOGIN ALFA (ACTIVATED),\"Drotrecogin alfa (activated) was initially used in the treatment of septic shock before it was withdrawn from the market. This medication was specifically aimed at managing septic shock, a severe condition, but due to various reasons, it is no longer available for this purpose.\",24\n13,SEPTIC SHOCK,HYDROCORTISONE-PLUS-FLUDROCORTISONE,\"The therapy was evaluated for its effectiveness in treating septic shock, showing a reduction in mortality\",21\n139,DROTRECOGIN ALFA (ACTIVATED),APROCCHSS TRIAL,Drotrecogin alfa (activated) was one of the treatments tested in the APROCCHSS trial for septic shock,14\n140,DROTRECOGIN ALFA (ACTIVATED),HYDROCORTISONE PLUS FLUDROCORTISONE,The potential interaction between drotrecogin alfa (activated) and hydrocortisone plus fludrocortisone was not assessed due to the withdrawal of Xigris from the market,11\n143,XIGRIS,APROCCHSS TRIAL,The trial continued with two parallel groups after Xigris was withdrawn from the market,11\n137,DROTRECOGIN ALFA (ACTIVATED),APROCCHSS,The APROCCHSS trial was designed to evaluate drotrecogin alfa (activated) among other therapies for septic shock before its withdrawal,9\n138,DROTRECOGIN ALFA (ACTIVATED),XIGRIS,\"Drotrecogin alfa (activated), also known as Xigris, is a medication that was available under the brand name Xigris. It was withdrawn from the market in 2011. Xigris served as the commercial form of drotrecogin alfa (activated), indicating that both names refer to the same product. The withdrawal applies universally to the product, regardless of the name it was marketed under.\",7\n136,HYDROCORTISONE-PLUS-FLUDROCORTISONE,APROCCHSS,The APROCCHSS trial evaluated the effectiveness of hydrocortisone-plus-fludrocortisone therapy in septic shock,6\n141,APROCCHSS,FRENCH MINISTRY OF SOCIAL AFFAIRS AND HEALTH,The APROCCHSS trial was funded by the French Ministry of Social Affairs and Health,5\n142,APROCCHSS,PROGRAMME HOSPITALIER DE RECHERCHE CLINIQUE 2007,The program funded the APROCCHSS clinical trial,5\n\n\nThe report should include the following sections:\n\n- TITLE: community's name that represents its key entities - title should be short but specific. When possible, include representative named entities in the title.\n- SUMMARY: An executive summary of the community's overall structure, how its entities are related to each other, and significant information associated with its entities.\n- IMPACT SEVERITY RATING: a float score between 0-10 that represents the severity of IMPACT posed by entities within the community.  IMPACT is the scored importance of a community.\n- RATING EXPLANATION: Give a single sentence explanation of the IMPACT severity rating.\n- DETAILED FINDINGS: A list of 5-10 key insights about the community. Each insight should have a short summary followed by multiple paragraphs of explanatory text grounded according to the grounding rules below. Be comprehensive.\n\nReturn output as a well-formed JSON-formatted string with the following format:\n    {{\n        \"title\": <report_title>,\n        \"summary\": <executive_summary>,\n        \"rating\": <impact_severity_rating>,\n        \"rating_explanation\": <rating_explanation>,\n        \"findings\": [\n            {{\n                \"summary\":<insight_1_summary>,\n                \"explanation\": <insight_1_explanation>\n            }},\n            {{\n                \"summary\":<insight_2_summary>,\n                \"explanation\": <insight_2_explanation>\n            }}\n        ]\n    }}\n\n# Grounding Rules\n\nPoints supported by data should list their data references as follows:\n\n\"This is an example sentence supported by multiple data references [Data: <dataset name> (record ids); <dataset name> (record ids)].\"\n\nDo not list more than 5 record ids in a single reference. Instead, list the top 5 most relevant record ids and add \"+more\" to indicate that there are more.\n\nFor example:\n\"Person X is the owner of Company Y and subject to many allegations of wrongdoing [Data: Reports (1), Entities (5, 7); Relationships (23); Claims (7, 2, 34, 64, 46, +more)].\"\n\nwhere 1, 5, 7, 23, 2, 34, 46, and 64 represent the id (not the index) of the relevant data record.\n\nDo not include information where the supporting evidence for it is not provided.\n\nOutput:", "parameters": {"model": "gpt-4-turbo-preview", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 2000, "n": 1}, "history": null}